New Product Launch

[Anonymous]

Don't be a fool and plan on staying here for a new drug launch. Many Pharmacy departments have already stated they will not take any future Mallinckrodt drugs to P&T for formulary no matter what it is. All you need to do is ask any of your close pharmacy contacts what they think and they will tell you to run for the hills. They may now have to work with Mallinckrodt in terms of pricing contracts with Ofirmev because what is done is done, but they will not allow another Mallinckrodt drug to be approved. Several physicians that had put their name on the line to push for Ofirmev only to be hit on the head with a triple price increase, will not make the same mistake again. So unless they are planning to be bought and there is a company name change, you can pretty much expect a disaster. Launching a new drug in the hospital is already an enormous and sometimes insurmountable task, but with these other factors it will be significantly worse.

 

[Anonymous]

Don't be a fool and plan on staying here for a new drug launch. Many Pharmacy departments have already stated they will not take any future Mallinckrodt drugs to P&T for formulary no matter what it is. All you need to do is ask any of your close pharmacy contacts what they think and they will tell you to run for the hills. They may now have to work with Mallinckrodt in terms of pricing contracts with Ofirmev because what is done is done, but they will not allow another Mallinckrodt drug to be approved. Several physicians that had put their name on the line to push for Ofirmev only to be hit on the head with a triple price increase, will not make the same mistake again. So unless they are planning to be bought and there is a company name change, you can pretty much expect a disaster. Launching a new drug in the hospital is already an enormous and sometimes insurmountable task, but with these other factors it will be significantly worse.

You don't have to worry about most hospitals with Offirmev since most have taken it off formulary.

 

[Anonymous]

You don't have to worry about most hospitals with Offirmev since most have taken it off formulary.

You misspelled ofirmev, asshole. Go troll somewhere else and don't forget to fist your Mother.

 

[Anonymous]

The post is dead on correct. Launching a drug under this company name would be terrible

 

[Anonymous]

Hold on one second. Did you show the customer the value proposition. Without showing them the value proposition you cant get out from underneath the cost increase. Without getting out from underneath the cost increase you cant be seen asset to that hospital and be able to appropriately partner with them to show them how they need any of our future products.
For God sakes man pull out the value proposition

 

[Anonymous]

Hold on one second. Did you show the customer the value proposition. Without showing them the value proposition you cant get out from underneath the cost increase. Without getting out from underneath the cost increase you cant be seen asset to that hospital and be able to appropriately partner with them to show them how they need any of our future products.
For God sakes man pull out the value proposition

The "value prop" and "partnering"...It's a straw man. The serious major league hospital systems can see right through it. Is MNK innovative enough to try and collaborate with other pharma companies that have skin in the game regarding pain protocols?

 

[Anonymous]

Hold on one second. Did you show the customer the value proposition. Without showing them the value proposition you cant get out from underneath the cost increase. Without getting out from underneath the cost increase you cant be seen asset to that hospital and be able to appropriately partner with them to show them how they need any of our future products.
For God sakes man pull out the value proposition

Thanks for the laugh today. I really needed it. Loved the sarcasm!

 

[Anonymous]

Classic!!!!